A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.

NCT03998319 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

445

Enrollment

OTHER

Sponsor class

Conditions

STEMI
Elevated IMR (>32)

Interventions

DRUG: Tenecteplase (1/3 systemic weight based dose)
OTHER: Sterile water for injection (WFI)

Sponsor

University of Sydney